R -citalopram functionally antagonises escitalopram in vivo and in vitro : evidence for kinetic interaction at the serotonin transporter (original ) (raw )The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors
Connie Sanchez
European Neuropsychopharmacology, 2005
View PDFchevron_right
The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse
aurelio vargas
Psychopharmacology, 2014
View PDFchevron_right
The Pharmacology of Citalopram Enantiomers: The Antagonism by R-Citalopram on the Effect of S-Citalopram*
Connie Sanchez
Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, 2006
View PDFchevron_right
An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: Kinetic binding studies with the ALI/VFL–SI/TT mutant
Connie Sanchez
Neuroscience Letters, 2009
View PDFchevron_right
Allosteric effects of R- and S-citalopram on the human 5-HT transporter: Evidence for distinct high- and low-affinity binding sites
Per Plenge
European Journal of Pharmacology, 2007
View PDFchevron_right
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram
Alexander Holik , Robert Dudczak
International Clinical Psychopharmacology, 2009
View PDFchevron_right
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [ 123 I]ADAM SPECT study
Alexander Holik , Robert Dudczak
Psychopharmacology, 2007
View PDFchevron_right
In vivo imaging of serotonin transporter occupancy by means of SPECT and [ 123 I]ADAM in healthy subjects administered different doses of escitalopram or citalopram
Alexander Holik , Robert Dudczak
Psychopharmacology, 2006
View PDFchevron_right
Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain
Bernard Renaud
Neuropsychopharmacology, 2005
View PDFchevron_right
Characterization of an allosteric citalopram-binding site at the serotonin transporter
Connie Sanchez
Journal of Neurochemistry, 2005
View PDFchevron_right
Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin Transporter
Flemming Jørgensen
Journal of Biological Chemistry, 2010
View PDFchevron_right
High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions
Per Plenge
Neuroscience Letters, 2005
View PDFchevron_right
[ 3 H]Citalopram Binding to Brain and Platelet Membranes of Human and Rat
Per Plenge
Journal of Neurochemistry, 1991
View PDFchevron_right
Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram
Jorn Arnt
Psychopharmacology, 1984
View PDFchevron_right
Improved Potency of Escitalopram on the Human Serotonin Transporter
Jeffrey Rausch, MD
Journal of Clinical Psychopharmacology, 2004
View PDFchevron_right
Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls
Matthew Taylor
Journal of Cerebral Blood Flow & Metabolism, 2008
View PDFchevron_right
Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the serotonin transporter
Claus J Loland
British journal of pharmacology, 2015
View PDFchevron_right
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats
Johan Ahlner
British Journal of Pharmacology, 2001
View PDFchevron_right
The Selective Serotonin Reuptake Inhibitor Citalopram Induces the Storage of Serotonin in Catecholaminergic Terminals
Heberto Suarez-Roca
Journal of Pharmacology and Experimental Therapeutics, 2002
View PDFchevron_right
R-citalopram prevents the neuronal adaptive changes induced by escitalopram
Anne Bérod
NeuroReport, 2007
View PDFchevron_right
Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram
Kim Brøsen
European Neuropsychopharmacology, 2001
View PDFchevron_right
Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets
Per Plenge
European Journal of Pharmacology: Molecular Pharmacology, 1991
View PDFchevron_right
Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies
Connie Sanchez
The International Journal of Neuropsychopharmacology, 2006
View PDFchevron_right
CITALOPRAM -ANXTIDEPRESSANT AND ANXIOLYTIC PROFILE OF SELECTIVE SEROTONIN UPTAKE INHIBITOR IN RATS
Muhammad Farhan
View PDFchevron_right
Selective inhibition of the serotonin transporter in the treatment of depression: Sertraline, fluoxetine and citalopram
Ede Frecska
Neuropsychopharmacologia Hungarica, 2020
View PDFchevron_right
Affinity modulation of [H]imipramine, [H]paroxetine and [H]citalopram binding to the 5HT transporter from brain and platelets
Pleng A.
European Journal of Pharmacology: Molecular Pharmacology, 1991
View PDFchevron_right
Escitalopram versus citalopram: the surprising role of the R-enantiomer
Klaus Bøgesø , Connie Sanchez
Psychopharmacology, 2004
View PDFchevron_right
Augmentation with a 5-HT1A, but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram
Fokko Bosker
European Journal of Pharmacology, 2000
View PDFchevron_right
Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium
Bertrand Rochat
Brain Research, 1999
View PDFchevron_right
Antidepressants Targeting the Serotonin Reuptake Transporter Act via a Competitive Mechanism
Marcos Milla
Journal of Pharmacology and Experimental Therapeutics, 2008
View PDFchevron_right
Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins
Per Plenge
European Journal of Pharmacology: Molecular Pharmacology, 1990
View PDFchevron_right
Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram
Fokko Bosker
European Journal of Pharmacology, 2000
View PDFchevron_right